The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.91B | 1.93B | 1.94B | 1.94B | 1.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91B | 1.93B | 1.94B | 1.94B | 1.94B |
| Cost of Revenue | 1.07B | 1.06B | 1.04B | 1.04B | 1.05B |
| Gross Profit | 845.38M | 871.23M | 895.49M | 893.86M | 895.77M |
| SG&A Expenses | 324.78M | 309.51M | 293.60M | 315.36M | 338.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 5.08M | 9.32M | 13.57M | 8.29M | 2.96M |
| Total Operating Expenses | 1.52B | 1.50B | 1.47B | 1.48B | 1.50B |
| Operating Income | 391.69M | 430.45M | 468.47M | 457.05M | 447.19M |
| Income Before Tax | 457.06M | 480.57M | 503.25M | 486.98M | 472.36M |
| Income Tax Expenses | 87.67M | 94.19M | 100.57M | 95.61M | 90.98M |
| Earnings from Continuing Operations | 369.39 | 386.38 | 402.68 | 391.37 | 381.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 262.20K | 176.90K | 91.10K | 81.20K | 71.40K |
| Net Income | 369.65M | 386.56M | 402.77M | 391.45M | 381.45M |
| EBIT | 391.69M | 430.45M | 468.47M | 457.05M | 447.19M |
| EBITDA | 472.54M | 508.18M | 542.93M | 532.23M | 523.42M |
| EPS Basic | 0.20 | 0.21 | 0.22 | 0.22 | 0.21 |
| Normalized Basic EPS | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 |
| EPS Diluted | 0.20 | 0.21 | 0.22 | 0.22 | 0.21 |
| Normalized Diluted EPS | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 |
| Average Basic Shares Outstanding | 7.27B | 7.27B | 7.27B | 7.27B | 7.27B |
| Average Diluted Shares Outstanding | 7.27B | 7.27B | 7.27B | 7.27B | 7.27B |
| Dividend Per Share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Payout Ratio | 30.14% | 22.91% | 16.22% | 16.69% | 17.13% |